Works about REGULATORY compliance


Results: 1292
    1
    2
    3
    4
    5
    6

    Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35960
    By:
    • Boyiadzis, Michael;
    • Wei, Andrew H.;
    • Paiva, Bruno;
    • Freeman, Sylvie D.;
    • Kaspers, Gertjan;
    • Chyla, Brenda;
    • Hersey, Sarah;
    • Patel, Reshma;
    • Maloney, Brian;
    • Blanchet Zumofen, Marie‐Helene;
    • Van Hoef, Marlies;
    • Wulff, Beate;
    • Obourn, Vanessa;
    • Patel, Shalaka;
    • Lopes de Menezes, Daniel;
    • Shi, Qian;
    • Bengoudifa, Bourras‐Rezki;
    • Dimier, Natalie;
    • Prior, Thomas J.;
    • Roboz, Gail J.
    Publication type:
    Article
    7
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    DLT Compliance Reporting.

    Published in:
    Complex Systems Informatics & Modeling Quarterly, 2023, n. 35, p. 92, doi. 10.7250/csimq.2023-35.04
    By:
    • Jensen, Johannes Rude;
    • Axelsen, Henrik;
    • Ross, Omri
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50